… Here, we present a series of patients with papillary thyroid carcinoma with squamous … the
TCV of papillary thyroid cancer. These tumors do have similarities in their aggressive histologic …

… The clinical importance of point mutations of ras oncogene in d#erentiated thyroid cancers
… in papillary thyroid carcinoma. Methods. Tumors of 91 patients with papillary carcinoma were …

… In the present study, the MIB1 LI was higher in the squamous cell carcinoma … and
aggressiveness in these thyroid neoplasms. In summary, primary SCT is a highly aggressive …

… Pathology and recurrence of aggressive papillary thyroid carcinoma subtypes smaller than
… Pathology and recurrence of aggressive papillary thyroid carcinoma subtypes smaller than or …

… Papillary thyroid carcinoma is the most common type of thyroid cancer, and the majority
of PTCs have an excellent prognosis with a 10 year survival rate of more than 90% [22,23]. …

… its target genes, including papillary thyroid cancer (PTC). … mRNA expression profiles in
aggressive PTC. miRNA and … and mRNAs between aggressive and non-aggressive PTCs. These …

… Background: The most common of the aggressive variant of papillary thyroid carcinoma (PTC)
is the tall cell variant (TCV). Because there are serious prognostic and management …

… , and apoptosis have been described in clinicopathologically aggressive thyroid neoplasms.
… in the columnar cell variant of papillary thyroid carcinoma, we screened for mutations in …

Context: Ten to 30% of patients with papillary thyroid cancer (PTC) develop recurrent disease
and may benefit from innovative adjuvant therapies. Immune-based therapies are under …

… papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more frequently
in patients with PTC showing aggressive … BRAF V600E mutation in tumor samples and its …